No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Zydelig (idelalisib) is a prescription medication used to treat certain types of leukemia. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Zydelig is approved for use in adults with chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). It is also approved for use in combination with other medications to treat relapsed small lymphocytic lymphoma (SLL).
Zydelig is manufactured by Gilead Sciences, Inc., a biopharmaceutical company based in California. The drug was approved by the U.S. Food and Drug Administration (FDA) in 2014. It is available in tablet form and is taken orally.
Other companies in the market include Novartis, Celgene, and AbbVie. These companies produce medications for the treatment of leukemia, including targeted therapies, immunotherapies, and chemotherapy. Show Less Read more
